Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lexicon, Tanox price IPOs

Lexicon Genetics (LEXG), which is developing knockout mice for target validation and drug discovery, on Thursday raised $220 million in its

Read the full 214 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE